VRTX — VERTEX PHARMACEUTICALS INC

Ownership history in Bridgefront Capital, LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which Bridgefront Capital, LLC reported a position in VERTEX PHARMACEUTICALS INC (VRTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.35% (2021 Q3)
Avg. % of fund
0.2%
First filed
2021 Q3
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 903 -64 -6.6% 0.10% $354K $391.64
2024 Q4 ADDED 967 +216 +28.8% 0.13% $389K $402.70
2022 Q2 REDUCED 751 -1,080 -59.0% 0.24% $212K $281.79
2021 Q3 INITIATED 1,831 — — 0.35% $332K $181.39
% of Fund (quarterly)    VRTX price (monthly, adj. close)

Other funds also holding VRTX

As of 2025 Q4 — sorted by position size

Provident Investment Management, Inc. 3Y 7Y 6.16% Bellevue Group AG 3Y 7Y 5.85% Andrew Hill Investment Advisors, Inc. 3Y 4.28% Iron Triangle Partners LP 3Y 3.99% Atle Fund Management AB 3Y 7Y 3.32% MCRAE CAPITAL MANAGEMENT INC 3Y 7Y 3.29% Sofinnova Investments, Inc. 3Y 7Y 3.22% SECTORAL ASSET MANAGEMENT INC 3Y 7Y 2.91% Birch Hill Investment Advisors LLC 3Y 7Y 2.89% NIA IMPACT ADVISORS, LLC 3Y 2.68%
← Back to Bridgefront Capital, LLC Holdings